Author: Chan Yeu Pu, MD, MS , Christine M. Lusk, MPH, Christine Neslund-Dudas, PhD, Shirish Gadgeel, MD, Ayman O. Soubani, MD, Ann G. Schwartz, MPH, PhD
Publication source: JTO Clinical and Research Reports
Country: USA
Date: August 01 2022
Summary of content: This study shows that lung cancer screening criteria should select candidates with minimal cardiopulmonary comorbidities who are fit for curative lung cancer resection.
The USPSTF 2021 qualifies an additional group of screening candidates who are healthier with better lung reserve, translating to better surgical candidacy but potentially more overdiagnosis. The PLCOm2012, with its better accuracy in selecting patients at risk of cancer, selects an older group with chronic obstructive pulmonary disease but with good lung reserve and potentially less over-diagnosis.
Link to document: https://www.jtocrr.org/article/S2666-3643(22)00101-1/fulltext
